Embed Size (px)
Citation preview
ESMO PRECEPTORSHIP PROGRAMME
COLORECTAL CANCER
Multidisciplinary management, standards of care and future perspectives
Barcelona, Spain 25-26 November 2016
CO-CHAIRS: Andrés Cervantes, Spain SPEAKERS: Frédéric Bibeau, France
Jean-Yves Douillard, Switzerland Michel Ducreux, France
Robert Glynne-Jones, United Kingdom
Claus-Henning Köhne, Germany
Pompiliu Piso, Germany
Hans-Rudolf Raab, Germany
Ramon Salazar, Spain
LEARNING OBJECTIVES
• To learn about best clinical practice in the multidisciplinary management of colorectal cancer in the adjuvant and
metastatic settings
• To understand the importance of pathology and histoprognostic factors
• To learn about the management of patients after progression, side-effects of treatments and in special situations
ACCREDITATION
The programme of this event has been accredited with 9 ESMO-MORA category 1 points.
Recertification is necessary for medical oncologists to remain professionally certified by ESMO. Recertification guarantees
that a certified medical oncologist has continued to update her/his knowledge and continues to possess the necessary
skills and standards for the practice of medical oncology. For further details, please refer to esmo.org.
ACKNOWLEDGEMENTS
This event is supported by an unrestricted educational grant from
ORGANISATION AND CONTACTS
ESMO Head Office Education Department Via Luigi Taddei 4 6962 Lugano - Viganello Switzerland Email: [email protected] www.esmo.org
Friday, 25 November 2016
09:00-9:15 15’
Welcome and introduction Andrés Cervantes, ES Jean-Yves Douillard, CH
09:15-10:50 95’
Session 1 Early colorectal cancer
Chair: Pompiliu Piso, DE
30’ The point of view of the pathologist
- - Quality and rules of a good pathology report
- - Histo-prognostic factors: Number of Lymph nodes, neural/lymphatic invasion, lymphocytic infiltration, MSH expression
Frédéric Bibeau, FR
20’ State-of-the-art: Standard of surgical practice for resectable colorectal cancer (special issues on rectal cancer)
Hans-Rudolf Raab, DE
30’ State-of-the-art: Standard(s) of radio/chemotherapy for rectal cancer Robert Glynne-Jones, UK
15’ Adjuvant chemotherapy of rectal cancer Andrés Cervantes, ES
10:50-11:10 Coffee Break
11:10-13:10 120’
Session 2 Adjuvant settings of colorectal cancer
Chair: Jean-Yves Douillard, CH
30’ Microsatellite instability and other molecular markers – how useful are they? Frédéric Bibeau, FR
30’ Adjuvant treatment for colon cancer III Claus-Henning Köhne, DE
30’ Adjuvant treatment of stage II: which patients to treat? Jean-Yves Douillard, CH
3x10’ 3 x Participant clinical case discussion All Faculty
13:10-14:10 Lunch
14:10-16:30 140’
Session 3 Metastatic colorectal cancer, liver limited metastases
Chair: Pompiliu Piso, DE
20’ Review of the ESMO consensus conference on metastatic colorectal cancer
- - Basic strategies and groups (RASwt /mut, BRAF mut)
Andrés Cervantes, ES
30’ Resection of liver limited metastases (Resectable cases, Group 0)
- - Upfront
- - After neo-adjuvant treatment
- - Repeated hepatectomy
Hans-Rudolf Raab, DE
30’ - Unresectable or borderline resectable (Group 1) chemotherapy +/- targeted agents
Claus-Henning Köhne, DE
30’ Options of locoregional treatment of liver metastases
- - Intra-arterial therapy
- - Chemo-embolisation
- - SIRT
- - Local radiation
Michel Ducreux, FR
3x10’ 3 x Participant clinical case discussion All Faculty
16:30-17:00 Coffee Break
17:00-18:30 90’
Session 4 Special clinical situations: Mono- or oligometastatic disease
Chair: Andrés Cervantes, ES
30’ Treatment of metastatic disease confined to the peritoneum
- - Resection
- - HIPEC
- - PIPEC
Pompiliu Piso, DE
30’ Primary with synchronous metastases Hans-Rudolf Raab, DE
30’ Chemotherapy and targeted agents in 1st line Ramon Salazar, ES
19:30 Dinner
Saturday, 26 November 2016
08:30-09:45 75’
Session 5 Metastatic colorectal cancer I
Chair: Jean-Yves Douillard, CH
50’ The role of maintenance, appropriate endpoints according to ESMO consensus Michel Ducreux, FR
25’ What to do after 1st line failure Andrés Cervantes, ES
9:45-10:15 Coffee Break
10:15-11:15 60’
Session 6 Metastatic colorectal cancer II
Chair: Andrés Cervantes, ES
30’ Management of treatment related side effects
- - GI-Toxicity
- - Neuropathy
- - Skin toxicity
- - Hypertension
- - Hand-foot syndrome
Michel Ducreux, FR
3x10’ 3 x Participant clinical case discussion All Faculty
11:15-12:00 45’
Session 7 Anal Canal tumours
Chair: Jean-Yves Douillard, CH
30’ Standard of care for Anal Canal Squamous carcinomas Robert Glynne-Jones, UK
15’ Salvage surgery of Anal Canal Squamous carcinomas Pompiliu Piso, DE
12:00-12:15 15’
Conclusion and farewell Chair: Andrés Cervantes, ES
12:15 Lunch
Note: Each 10 minute slot for clinical case discussion includes 5’ case presentation and 5’ Q&A / panel discussion
